Peter Ressalehi
CHIEF EXECUTIVE OFFICER
Peter has over 20 years of experience as a serial entrepreneur within various industries such as private equity, agriculture, retail and Pharmaceutical Industries. He has solid international experience in financial management, corporate development, corporate governance, and advisory experience with private companies across multiple industry sectors. He started MIM Pharma in 2013 as co-founder with Dr. Reza Ramazani with the vision and drive to develop a novel anti-migraine medicine for patients with episodic and chronic headaches. Peter graduated from the Norwegian School of Management (BI) with a bachelor’s degree in finance (2000). Private Equity, Financing, Investing, and Value Creation program - London Imperial College Business School (2021)
- Phone:+47 98 10 10 10
- Email:pr@mimpharma.com
Dr. Reza Ramazani
CHIEF SCIENTIFIC OFFICER
Dr. Reza Ramezani is Co-founder and professional leader in MIM Pharma's research team and has over 33 years of experience in the pharmaceutical industry. He has solid experience and is an expert in Complex Modeling, Systemic Research and Comprehensive Innovation and Creativity System management.
He holds a Ph.D. in Systems Engineering from Case Western Reserve University, Cleveland, Ohio, USA, and teaching in (Ph.D., MS, MA, BS) Systems Analysis and Design, Decision Making Theory, Systemic Research Methods, Linear Programming, Non-Linear Programming, Mathematical Modeling, Innovation and creativity systems with the supervision of 95 Ph.D. dissertations and master theses and 57 publications (1992- now)
Selected Publications Design of a Fault Detection Expert System to Diagnose Errors in the Polypropylene Production Process, Journal of Industrial and Systems Engineering (2022, accepted paper, under revision) Efficacy of a multiple-indication antiviral herbal drug (Saliravira® ) for COVID-19 outpatients: A pre-clinical and randomized clinical trial study, Biomedicine & Pharmacotherapy, Volume 149, May 2022 DOI: 10.1016/j.biopha.2022.112729 The Effectiveness of Using AllergyCut® in the Allergic Rhinitis Treatment, The International Congress of, Immunotherapy and Allergy and (ICIA), Tehran, 2018 More than two decades of R&D efforts on migraine headaches in Iran, 13th Congress of Iranian Pain Society, Tehran, November 1-3, 2017 Strategic Planning with a top-down approach: a case study of the Iranian Academy of Medical Sciences, 8th International Industrial Engineering Conference, Tehran, February 2013
Selected Publications Design of a Fault Detection Expert System to Diagnose Errors in the Polypropylene Production Process, Journal of Industrial and Systems Engineering (2022, accepted paper, under revision) Efficacy of a multiple-indication antiviral herbal drug (Saliravira® ) for COVID-19 outpatients: A pre-clinical and randomized clinical trial study, Biomedicine & Pharmacotherapy, Volume 149, May 2022 DOI: 10.1016/j.biopha.2022.112729 The Effectiveness of Using AllergyCut® in the Allergic Rhinitis Treatment, The International Congress of, Immunotherapy and Allergy and (ICIA), Tehran, 2018 More than two decades of R&D efforts on migraine headaches in Iran, 13th Congress of Iranian Pain Society, Tehran, November 1-3, 2017 Strategic Planning with a top-down approach: a case study of the Iranian Academy of Medical Sciences, 8th International Industrial Engineering Conference, Tehran, February 2013
- Phone:+47 98 10 10 10
- Email:dr.ramazani@mimpharma.com
Mona Hedvig Myhre
CHIEF SAFETY AND COMPLIANCE OFFICER
Mona joined MIM Pharma in February. She brings over 25 years’ experience having held a wide variety of leadership roles, within Pharmaceutical Industry from positions in Roche AS, Pharmacia and Upjohn AS, Pharmacia AS, Leo Løvens kemiske fabrikk, Knut Spærens Laboratorier, Travenol Laboratories. She has been responsible for launching the company's most innovative and novel products in new challenging markets. She was responsible for the preparation and implementation of the product launch, strategic and tactical marketing plans, training of sales staff, contact with key opinion leaders and public relations. Experience with various market areas such as OTC (over the counter), prescription drugs for humans and drugs for animals. Experience with chemical and hygienic control of drug production. MS in chemical process industry, Østfold Technical High-school (1978) and a MBA in International Marketing Management, BI Norwegian Business School (1993), Certified NLP Coach Richard Bandler (2017).
- Phone:+47 98 10 10 10
- Email:Mona.h.myhre@mimpharma.com
Saleh Ramazani
DIRECTOR OF LAB AND DRUG FORMULATION
Saleh joined MIM Pharma as Co-founder and Director of Lab and Drug formulation. He has over 10 years of experience in Drug formulation, Lab Operations and Management, Clinical Trials and Pharmaceutical Regulatory.
MS, BS PhAC Regulatory, Cellular Biologist - Tehran University Medical Schools (TUMS)
Selected Publications Efficacy of a multiple-indication antiviral herbal drug (Saliravira® ) for COVID-19 outpatients: A pre-clinical and randomized clinical trial study, Biomedicine & Pharmacotherapy, Volume 149, May 2022 DOI: 10.1016/j.biopha.2022.112729
Selected Publications Efficacy of a multiple-indication antiviral herbal drug (Saliravira® ) for COVID-19 outpatients: A pre-clinical and randomized clinical trial study, Biomedicine & Pharmacotherapy, Volume 149, May 2022 DOI: 10.1016/j.biopha.2022.112729
- Phone:+47 98 10 10 10
- Email:Saleh.ramazani@mimpharma.com
Fateme Azadnia
DIRECTOR OF CLINICAL OPERATIONS
Fateme has contributed MIM Pharma in Clinical Operations. She has over 5 years of experience in Cellular Therapy and Clinical Trials.
MS, BS Cellular, Mol. Biology, Genetics - Al-Zahra University of Tehran
Selected Publications Efficacy of a multiple-indication antiviral herbal drug (Saliravira® ) for COVID-19 outpatients: A pre-clinical and randomized clinical trial study, Biomedicine & Pharmacotherapy, Volume 149, May 2022 DOI: 10.1016/j.biopha.2022.112729
Selected Publications Efficacy of a multiple-indication antiviral herbal drug (Saliravira® ) for COVID-19 outpatients: A pre-clinical and randomized clinical trial study, Biomedicine & Pharmacotherapy, Volume 149, May 2022 DOI: 10.1016/j.biopha.2022.112729
- Phone:+47 98 10 10 10
- Email:mim@mimpharma.com
Jeanette Ressalehi
HEAD OF MARKETING
Jeanette joined MIM Pharma as Head of Marketing. She brings 10 years of marketing experience from the media industry in The Norwegian Business Daily and a digital marketing agency Frantz AS. Last 4 years she has been in the Pharma industry where she has been working for Roche Diagnostics and Boehringer Ingelheim. She has held different roles such as Product Manager, Multichannel Manager, and Marketing Manager.
Bachelor’s in marketing and Sales Management, Kristiania University College
- Phone:+47 98 10 10 10
- Email:jr@mimpharma.com
